US 8066985
Reovirus for the treatment of cellular proliferative disorders
granted A61KA61K35/765A61K9/0019
Quick answer
US patent 8066985 (Reovirus for the treatment of cellular proliferative disorders) held by ONCOLYTICS BIOTECH INC. expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ONCOLYTICS BIOTECH INC.
- Grant date
- Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K35/765, A61K9/0019, A61P, A61P31/12